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Escherichia coli-mycobacterium shuttle vectors are important tools for gene expression and gene replacement in mycobacteria.
However, most of the currently available vectors are limited in their use because of the lack of extendedmultiple cloning sites
(MCSs) and convenience of appending an epitope tag(s) to the cloned open reading frames (ORFs). Here we report a new series
of vectors that allow for the constitutive and regulatable expression of proteins, appended with peptide tag sequences at their N
and C termini, respectively. The applicability of these vectors is demonstrated by the constitutive and induced expression of the
Mycobacterium tuberculosis pknK gene, coding for protein kinase K, a serine-threonine protein kinase. Furthermore, a suicide
plasmid with expandedMCS for creating gene replacements, a plasmid for chromosomal integrations at the commonly used L5
attB site, and a hypoxia-responsive vector, for expression of a gene(s) under hypoxic conditions that mimic latency, have also
been created. Additionally, we have created a vector for the coexpression of two proteins controlled by two independent promot-
ers, with each protein being in fusion with a different tag. The shuttle vectors developed in the present study are excellent tools
for the analysis of gene function in mycobacteria and are a valuable addition to the existing repertoire of vectors for mycobacte-
rial research.
Mycobacterium tuberculosis is the single largest cause of mor-bidity and mortality by a bacterial pathogen. Its complex
physiology and ability to survive in hostile environments, coupled
with the serious trend of a rise in multidrug-resistant (MDR) and
extensively drug-resistant (XDR) tuberculosis cases, has necessi-
tated the renewal of efforts to understand themolecular basis of its
pathogenesis (1). The analysis of gene expression patterns and the
availability of molecular genetics tools are central to the study of
the physiology and pathogenesis of any pathogen.
The molecular genetics of mycobacteria was first investigated
in 1979, with the identification of plasmids from Mycobacterium
avium (2, 3). Several plasmids in various other species of myco-
bacteria, like Mycobacterium scrofulaceum (4), Mycobacterium
chelonae (5), and Mycobacterium fortuitum (6), and linear plas-
mids from Mycobacterium xenopi, Mycobacterium branderi, and
Mycobacterium celatum (7) have since been identified. The origin
of replication identified fromM. fortuitum plasmid pAL5000 was
widely explored and quickly became a foundation for the devel-
opment of Escherichia coli-mycobacterium shuttle vectors (6,
8–10).
Routinely used shuttle vectors, such as pMV261, express genes
constitutively under the control of the hsp60 gene promoter
(Phsp60) (11–13), while the pMF series of vectors carry M. tuber-
culosis furA promoters to allow different levels of gene expression
(14). However, when the expressed proteins are toxic, or when
conditional gene replacement mutants are sought, it is necessary
to tightly regulate the expression of the genes of interest. A num-
ber of systems are currently available for regulatable expression of
genes in mycobacteria. Among these, the acetamidase-inducible
systems controlled by two positive regulators, AmiC and AmiD,
and a negative regulator, AmiA, were the first inducible promoter
systems to be developed (15–17). Other inducible systems devel-
oped over the years include pGB-T7 RNA polymerase (RNAP),
which utilizes the IPTG (isopropyl--D-thiogalactopyranoside)-
inducible T7 promoter system, pNIT-1, which carries the
isovaleronitrile-inducible gene expression system (18), pMY696,
which has a pristinamycin-inducible system (19), and tetracycline
(Tet)-inducible systems (20–22).
The Tet-inducible expression systems rely on induction by tet-
racycline or its analogs (23). Based on the source of these tetracy-
cline regulatory systems, they are further classified as E. coli Tn10-
derived pMC1s, pTACT21 and pSE100 plasmids (21, 22, 24), the
Corynebacterium glutamicum TetZ locus-derived pMind vector
(20), and the Streptomyces coelicolor tcp830 promoter and opera-
tor-derived pMHA series of vectors (23). The promoter is modu-
lated by the interaction of the Tet repressor (TetR) with its oper-
ator sequence within the promoter, resulting in inhibition of
transcription. Subsequent to the interaction of tetracycline or its
analogs with TetR, the repressor-operator interaction is lost, re-
sulting in the activation of transcription. The Tet system has
proven successful in regulating inducible expression in the patho-
gen even within the host macrophages (20, 23). The efficacy of the
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TetR-operator interaction has been increased50-fold by muta-
tion of the gene in accordance with codon usage inM. tuberculosis
in order to improve TetR expression (25). In addition, the tetR
gene has been engineered to produce reverse TetR, wherein the
addition of tetracycline or its analogs induces interaction of the
repressor with the operator sequence, thus resulting in gene re-
pression (25). Together, the two systems provide powerful means
to regulate the expression of genes and aid in generating condi-
tional gene replacement mutants for investigation of the events of
molecular physiology in mycobacteria.
Unlike the commercially available E. coli expression vectors,
M. tuberculosis shuttle vectors lack extendedmultiple cloning sites
(MCSs), convenient epitope tags, or smaller size. These vectors
also do not always allow the expression of genes under different
physiological conditions. This report presents the results of our
efforts to create a series of vectors possessing expandedMCSs that
allow the constitutive or inducible expression of genes in fusion
with hexahistidine (6His) and FLAG tags at theN andC termini,
respectively. In addition, the vectors have been further modified
for expression of the cloned gene under hypoxic conditions. Thus,
these vectors are an important addition to the assortment of vec-
tors presently available for mycobacterial research.
MATERIALS AND METHODS
Reagents, bacterial strains, and growth conditions. Restriction/modifi-
cation enzymes were obtained from NEB and MBI-Fermentas. DNA oli-
gomers (see Table S2 in the supplemental material) and analytical-grade
chemicals were purchased from Sigma.Mycobacterium smegmatismc2155
was grown onDifcoMiddlebrook 7H10 agar (Becton, Dickinson) supple-
mented with 10% oleic acid-albumin-dextrose-catalase (OADC) and
0.2% glycerol at 37°C. For suspension culture,M. smegmatiswas grown in
7H9 broth (Becton, Dickinson) supplemented with 10%ADC, 0.2% glyc-
erol, and 0.05%Tween 80. E. coliDH5was grown inDifco Luria-Bertani
broth (BectonDickinson) at 37°C. LBCT (Luria-Bertani broth, 0.2% dex-
trose, 0.2% glycerol, and 0.05% Tween 80) and LBC agar (Luria-Bertani
broth, 0.2% dextrose, 0.2% glycerol, 1.5% agar) media were used to grow
M. smegmatis cells wherever stated. The following antibiotic supplements
were used: kanamycin (50 g/ml for E. coli and 25 g/ml for mycobacte-
ria), hygromycin (150g/ml for E. coli and 100g/ml for mycobacteria),
apramycin (30 g/ml), and ampicillin (100 g/ml). The bacterial strains
and plasmids used in this study are listed in Table S1 in the supplemental
material.
Mycobacterial transformation and expression of recombinant pro-
teins. M. smegmatis mc2155 and M. tuberculosis H37Rv competent cells
were prepared as described previously (26, 27). Freshly made competent
cells (200l) were electroporatedwith 200 to 400 ng of plasmidDNA. For
the analysis of constitutive expression of proteins,M. smegmatis cultures
were incubated for 24 h. For analysis of inducible expression, cultures
were grown to an optical density at 600 nm (OD600) of0.6, inducedwith
different concentrations of anhydrotetracycline (ATc; 0 to 1,000 ng/ml),
and further incubated for 14 h and 72 h for M. smegmatis and M. tuber-
culosis, respectively. Cells were harvested, resuspended in lysis buffer
(phosphate-buffered saline [PBS] containing 5% glycerol [PBSG]), and
lysed using 0.1-mm zirconia beads, in a Mini-BeadBeater (BioSpec Prod-
ucts). The lysates were clarified by centrifugation at 16,100 g for 30min
at 4°C, and protein concentrations were estimated. Clarified lysates con-
taining 10 to 50 g total protein were resolved on 8-to-12% SDS-PAGE
gels and transferred to polyvinylidene difluoride (PVDF)/nitrocellulose
membranes. Western blotting was performed as described earlier (28).
Generation of constitutive and inducible shuttle vectors. The E. coli
origin of replication (oriE), M. tuberculosis origin of replication (oriM),
and hygromycin resistance (Hygr) gene (hph) cassettes were amplified
from plasmid pVV16 (TBVRM, Colorado State University), using gene-
specific primers and Phusion DNA polymerase. The vector pSE100 (24)
was used as the template for amplification of sequence of Pmyc1tetO (a
promoter with a tet operator). The amplicons obtained were then cloned
into the pENTR/D-TOPO vector (Invitrogen). The internal EcoRI site in
hph (Hygr) was destroyed with the help of overlapping PCR mutagenesis
to produce pENTR-Hygrmod. The oriM and Hygrmod cassettes were released
by SnaBI-KpnI and KpnI-EcoRV digestions, respectively, and subcloned
into SnaBI-EcoRV sites on pENTR-oriE, generating pENTR-EMH (con-
taining oriE, oriM, and Hygrmod). The Pmyc1tetO cassette was released by
ScaI-EcoRV digestion and cloned into corresponding sites on pENTR-
EMH to create plasmid pENTR-EMHPmyc1tetO[r]. The nucleic acid se-
quence specific to pENTR was removed by HpaI digestion followed by
recircularization, to generate pEMHPmyc1tetO[r]. Adaptor primer du-
plexes containing the ribosomal binding site (RBS), hexahistidine tag,
MCS, FLAG tag, and transcription terminator sequence were cloned into
SphI-HpaI-digested pEMHPmyc1tetO[r] to generate shuttle vector pST-H
(Fig. 1).
A cassette encoding tetracycline repressor (tetR) under the control of
an intermediate-strength promoter, PimyctetR, was amplified from
pMC1m (kind gift from S. Ehrt) and cloned into pENTR/D-TOPO vec-
tor. Several sites were mutated either in the promoter or in the wobble
base of the codons (by overlapping PCRmutagenesis) to obliterate inter-
nal BamHI, KpnI, XbaI, HindIII, ApaI, SnaBI, and NdeI restriction sites
without altering the protein’s coding sequence. Themodified cassette was
released by SnaBI and cloned into the pST-H vector to generate the
pST-HT construct. All vectors generated were verified by restriction di-
gestion and DNA sequencing analysis.
In order to generate shuttle vectors with the kanamycin resistance
gene (aphA), the MluI-HpaI fragment containing oriE and the aphA
(Kanr) gene from pVV16 was cloned into the corresponding sites in
pST-H and pST-HT to generate vectors pST-KH and pST-KHT, contain-
ing both Hygrmod and aphA (Kanr) genes. Subsequently, the Hygrmod gene
was removed by Acc65I-NarI digestion followed by filling in with Klenow
polymerase and religation, to generate pST-K and pST-KT. (The Acc65I/
KpnI site is regenerated.) The XbaI-HindIII fragment from pENTR-pknK
containing a 3.3-kb protein kinase K gene (pknK) (29) was subcloned into
corresponding sites in pST-K and pST-KT to create the pST-K-pknK and
pST-KT-pknK plasmids, respectively.
Generation of constitutive and inducible integrating vectors. The
attP site and the integrase gene (int) of mycobacteriophage L5 were am-
plified from pMV361 (12) using specific primers, and the amplicon ob-
tained was cloned into pENTR/D-TOPO vector to generate pENTR-int.
Overlapping PCR mutagenesis was performed to eliminate the internal
restriction sites BamHI, PstI, andNdeI in the attP-int fragment. The oriM
gene was released from the pST-K and pST-KT vectors by SnaBI-KpnI
digestion and replaced with the SnaBI-KpnI attP-intmod fragment from
pENTR-intmod to generate pST-Ki and pST-KiT, respectively. The M.
tuberculosis H37Rv pknK gene was subcloned from pENTR-pknK to
pST-Ki and pST-KiT, as described above, to generate pST-Ki-pknK and
pST-KiT-pknK, respectively.
Generationof a suicidedelivery vector for gene replacement studies.
TheAcc65I-SnaBI oriM fragment in pENTR-EMHwas replaced by Phsp60-
sacB, amplified from pGOAL17 (30), resulting in pENTR-ESH. Subse-
quently, pENTR sequence was deleted and T4-PNKphosphorylatedDNA
oligomer duplex containing MCS sequence was cloned into the SpeI site
to generate the suicide delivery vector pST-KO. To validate the utility of
pST-KO, we produced an M. smegmatis mc2155 ilvH gene replacement
mutant (mc2ilvH). Approximately1.1 kb of 5= and 3= flank sequences
of the ilvH gene (including 100 bp of 5=- and 3=-end sequences of the
gene) was amplified and cloned in the pENTR-D-TOPO vector. The
aacC41 gene (1.1 kb) exhibiting the apramycin resistance (Aprr) pheno-
type was amplified from pMV261apra and cloned into pENTR-D-TOPO
vector. The 5= flank, aacC41 gene sequence, and 3= flank sequence were
released by PstI-ScaI, ScaI-ScaI, and ScaI-NotI, respectively, and cloned
into pQEII (Qiagen) vector digested with PstI-NotI. The entire cassette
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was digested with SmaI-NotI enzymes and cloned into corresponding
sites on pST-KO. The EcoRV-linearized pST-KO-ilvH construct was
electroporated intoM. smegmatis and selected for Hygr transformants.
Two of the Hygr transformants were grown in LBCT broth in the
absence of hygromycin for 24 h, serially diluted, and plated on LBC agar
plates containing 10% sucrose, followed by incubation at 37°C for 36 h to
select for homologous recombinants (double-crossover strains [DCOs]).
Sixty sucrose-resistant colonies were inoculated in apramycin-containing
LBCTbroth, incubated at 37°C for 24 h, and subsequently spotted on LBC
agar plates containing only apramycin or both apramycin and hygromy-
cin. To confirm the deletion of the ilvH gene, we tested for auxotrophy for
branched-chain amino acids (BCAAs; Leu, Ile, andVal). This was done by
replica spotting apramycin-resistant and hygromycin-sensitive (Aprr
Hygs) colonies onto 7H10 agar plates containing only apramycin, apra-
FIG 1 Schematic depiction of creation of constitutive and inducible shuttle vectors. rbs, ribosome binding site.
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mycin andBCAA, or hygromycin andBCAA.Colonies that appeared only
in apramycin with BCAA were expected to be the desired knockouts (see
Fig. S1 in the supplemental material). The genomic deletion was verified
by PCR amplification across the deletion junctions using appropriate
primers and analyzing the PCR products for expected fragment length
polymorphisms in comparison with the wild type.
Generationof hypoxia-inducible shuttle vector.Thehypoxia-induc-
ible narK2 promoter (PnarK2) was amplified from pTrc-narK2 vector (31)
and cloned into pENTR-D-TOPO vector. pENTR-narK2 vector was di-
gested with ScaI-SphI, and the 304-bp PnarK2 promoter thus released was
cloned into corresponding sites on pST-K, replacing Pmyc1tetO with
PnarK2 to generate the pST-KnarK2 vector. In order to demonstrate hypox-
ia-attributed responsiveness of the narK2 promoter in pST-KnarK2, the
1-kb EcoRI-HindIII fragment from pMV-gfpaav (31, 32), which codes
for adeno-associated virus green fluorescent protein (GFPaav) along with
a short tag that confers a half-life of 40 min, was cloned into the corre-
sponding sites in pST-KnarK2 and transformed intoM. smegmatis. Trans-
formants were inoculated into Dubosmediumwith 10%ADC and grown
to an OD600 of 0.6, and the cultures were diluted (1:100) in 20 ml of
fresh medium and 10 ml of air space (headspace ratio of 0.5 [33]) in
flat-bottom screw-cap tubes with magnetic beads (34). Methylene blue
indicator dye was added to a final concentration of 1.5 g/ml. The tubes
were sealed and incubated on a magnetic stirrer at 37°C for 10 days (35).
For the ascorbic acid treatment, methylene blue indicator dye was
added to the early-log-phase culture grown to anOD600 of0.3, followed
by the addition of ascorbic acid solution to a final concentration of 10
mM. The tubes were sealed with Parafilm and incubated at 37°C for 12 h.
Cells were harvested after 12 h and processed as described before. Briefly,
cells were collected by centrifugation at 10,000  g at 4°C. The bacteria
were fixed in PBS (pH 7.2) containing 1.5% paraformaldehyde, and the
fixed samples were stored at 4°C until further use. Fixed samples were
subjected to flow cytometry analysis and microscopy to check the expres-
sion of adeno-associated virus green fluorescent protein (GFPaav).
Generation of dual-expression vector. Double-stranded DNA oli-
gomers carrying Shine-Dalgarno sequence 1 (SD1), 6His tag, multiple
cloning site 1 (MCS1), SD2, MCS2, FLAG tag, and transcriptional termi-
nator sequence 2 (Term2) were systematically cloned into SphI-HpaI-
treated pEMHPmyc1tetO[r]. The antibiotic selectionmarker was switched
from Hygr to Kanr, as described earlier. The vector pMC1s (22) was used
as the template for amplification of Psmyc (a promoterwithout tetoperator
sequences for constitutive expression), and the amplicon was cloned into
an entry vector. The Psmyc promoter was released from the entry vector
and subcloned in the NotI-ApaI sites upstream of SD2. Additional tran-
scriptional terminator sequence Term1 was introduced after the NotI site
in the firstMCS byDNAoligomer duplex cloning, to generate the pST-2K
vector. The pknB-KD (990-bp) and garA (498-bp) gene fragments were
amplified from M. tuberculosis H37Rv bacterial artificial chromosome
(BAC) clones (a kind gift from S. T. Cole [36]) using gene-specific prim-
ers. The NdeI-NotI-digested pknB-KD amplicon was cloned into the cor-
responding sites in MCS1, and the HindIII-digested garA amplicon was
cloned into the HindIII site in MCS2. The amplification of pknK and virS
was carried out as described previously (29). The pknK gene was cloned
into the XbaI site in MCS1, and the virS gene was cloned into the HindIII
site in MCS2.
Nucleotide sequence accession numbers. The sequences of vectors
reported in this article have been deposited in GenBank under accession
no. KC153033 (pST-K), KC153038 (pST-KT), KC153034 (pST-Ki),
KC153035 (pST-KiT), KC153037 (pST-KO), KC153036 (pST-narK2),
and KC153032 (pST-2K).
RESULTS AND DISCUSSION
Vectors pST-K and pST-KT permit constitutive and inducible
expression of proteins inM. tuberculosis. Several mycobacterial
vectors permitting constitutive or inducible expression of pro-
teins are currently available from various sources. However, one
of themajor limitations ofmost of these vectors is the unavailabil-
ity of expanded restriction endonuclease sites for cloning of the
gene(s) of interest, in addition to the lack of epitope tags at one or
both ends of the expressed proteins. The present study was under-
taken to expand and improve upon the existing array ofmycobac-
terial expression vectors. The essential features of the shuttle vec-
tors, the origins of replication from E. coli (oriE) and M.
tuberculosis (oriM), antibiotic resistance markers (Hygr or Kanr),
promoters, ribosome binding sites, epitope tags, multiple cloning
sites (MCS), and transcription terminator sequences were put to-
gether by amplifying the different components from various plas-
mids and cloning them stepwise or by cloning DNA oligomers
carrying the desired sequences. The approach used is outlined in
Fig. 1, and the details are described in Materials and Methods.
Briefly, the oriE, oriM, and Hygr DNA fragments were amplified
from shuttle vector pVV16 (TBVRM, Colorado State University).
The tetracycline-inducible promoter Pmyc1tetO was amplified
frompSE100 (24), and the tetracycline repressor (tetR) along with
its promoter was amplified from pMC1m, and all fragments were
cloned into the entry vector. In order to abolish the restriction
sites within the Hygr and tetR genes, we have introduced silent
point mutations by overlapping PCR mutagenesis. To introduce
the ribosome binding site (RBS) sequence, His tag, MCS, FLAG
tag, and transcriptional terminator sequence, we cloned in appro-
priately designed DNA oligomers (see Table S2 in the supplemen-
tal material). The constitutive shuttle vector (pST-H) thus gener-
ated (Fig. 1 and see Materials and Methods) had a significantly
expandedMCS, with 12 restriction enzyme sites and defined pep-
tide sequences (6His and FLAG) fused at both ends (Fig. 2A).
The modified tetR gene (tetRmod) was then introduced in pST-H
to generate the tet-inducible pST-HT vector. As hygromycin re-
sistance often serves as amarkerwhen a creating gene replacement
mutant(s) (37–40), pST-K and pST-KT were created from pST-H
and pST-HT by introducing the kanamycin resistance gene in
place of the hygromycin resistance gene (Fig. 1).
M. tuberculosis codes for 11 eukaryotic-like serine/threonine
protein kinases (eSTPKs), which have been shown to modulate
various cellular functions (41). Protein kinase K (PknK) is the
largest kinase in mycobacteria and has been reported to be non-
essential to the cell’s survival (29, 42). To determine if the vectors
pST-K and pST-KT could be successfully used for protein expres-
sion, we cloned the 3.3-kb pknK gene into the plasmids.While the
promoter Pmyc1tetO contains the tet operator sequence (tetO), in
the absence of the repressor, it remains constitutively active; thus,
the protein must be constitutively expressed from pST-K and ex-
pressed only upon induction from pST-KT. As evident from
Western blot analysis of lysates made from M. smegmatis trans-
formed with pST-K-pknK, the protein is robustly expressed (Fig.
2B) from this plasmid. While the endogenous PknK could not be
detected under the experimental conditions, it can be visualized
when larger amounts of lysates are loaded (data not shown). As
expected, in pST-KT vector (containing tetRmod) we could not
detect expression of PknK in the absence of the inducer anhydro-
tetracycline (ATc) (Fig. 2C). PknK expression could be detected in
M. smegmatis extracts made from cells induced by concentrations
of ATc as low as 5 ng/ml (Fig. 2C). The expression levels increased
with increasing concentrations of the inducer, with maximum
expression seen at 25 ng/ml ATc, which is in keeping with an
earlier report (22). In order to check the efficacy of the inducible
vector in M. tuberculosis H37Rv, we transformed the strain with
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pST-KT and pST-KT-pknK.We found that theATc concentration
required for robust expression was about 10-fold higher in M.
tuberculosis than that inM. smegmatis (Fig. 2D). Furthermore, we
observed that expression of PknK could be detected as early as 24
h after induction, and expression was sustained at similar levels
until 72 h after induction (Fig. 2E, lanes 4, 5, and 6). In a previous
study using -galactosidase as the reporter gene, investigators
demonstrated effective expression from a Tet-inducible promoter
inM. tuberculosis at a 25-ng/ml ATc concentration (22). This ap-
parent difference in suitable inducer concentrationsmay be due to
the sensitivity of the-galactosidase assay compared to the immu-
noblot assay for PknK. However, it is clear that saturating levels of
expression are being attained only at higher ATc concentrations of
about 250 ng/ml. This may also be related to the different levels
of expression of TetR from the different plasmids.
The integrating vectors pST-Ki and pST-KiT control consti-
tutive and inducible expression of proteins. The copy numbers
of episomal vectors having the pAL5000 origin of replication
(oriM) have been reported to be 3 by Southern hybridization (8)
and 8 by single-cell antibiotic resistance assay (43). However, us-
ing a more reliable quantitative PCR (qPCR) method, the copy
number inM. smegmatis was shown to be23 (44). The expres-
sion levels of proteins vary, depending on the strain, suggesting
that the copy number of the vector is also dependent on the host
strain (45). When expressing genes that are detrimental to cell
growth if overexpressed, it is disadvantageous to express them
from multicopy episomal plasmids. In these cases, it is beneficial
to express the protein from single-copy chromosomal integrants.
Integrase- or recombinase-directed site-specific chromosomal in-
tegrations have been used inmany organisms. Themycobacterio-
phage L5 (L5) integrase-based system has been extensively used
to generate integration proficient vectors (12, 46). To derive inte-
grating vectors from pST-K and pST-KT, we swapped the region
containing the oriM with a fragment containing the modified in-
tegrase gene (intmod) and the attP sites of the L5 phage to create
vectors pST-Ki and pST-KiT (Fig. 3A), respectively. The efficacy
of these vectors was checked by cloning the pknK gene into the
MCS of either pST-Ki or pST-KiT and transforming the resulting
constructs into M. smegmatis. In keeping with results obtained
with the expression vector pST-K-pknK, we observed constitutive
expression of PknK when pST-Ki-pknK was electroporated into
M. smegmatis (Fig. 3B). Upon transformation of M. smegmatis
with pST-KiT-pknK, we detected expression of PknK at ATc con-
centrations as low as 5 ng/ml (Fig. 3C). Apart from L5-based
FIG 2 Expression of M. tuberculosis PknK using replication-proficient vectors in mycobacteria. (A) Sequence of multiple cloning site (MCS) of pST-K and
pST-KT vectors. The ribosomal binding site (rbs), peptide tags, and restriction enzyme sites are as indicated. (B) Constitutive expression of PknK in M.
smegmatis.Whole-cell extracts were prepared fromM. smegmatismc2155 electroporatedwith pST-K or pST-K-pknK.Tenmicrograms and 25g of extracts were
resolved on 8% SDS-PAGE gels, transferred onto PVDF membranes, and probed with rabbit polyclonal anti-PknB (-PknB) and anti-PknK (-PknK)
antibodies, respectively. (C) Regulated expression of PknK inM. smegmatis. Cultures ofM. smegmatis transformed with pST-KT or pST-KT-pknK were grown
to an OD600 of0.6 and induced with various concentrations of ATc (as indicated). Cell lysates were processed as described above. (D) Regulated expression of
PknK inM. tuberculosisH37Rv. Cultures ofM. tuberculosisH37Rv transformedwith pST-KTor pST-KT-pknKwere grown to anOD600 of0.6 and inducedwith
various concentrations of ATc as indicated for 72 h. Tenmicrograms (for PknB) and 50g (for PknK and GroEL1) of extracts were resolved on 10% SDS-PAGE
gels, transferred to nitrocellulose membranes, and probed with rabbit anti-PknB, anti-PknK, and anti-GroEL1 (-GroEL1) antibodies. (E) Cultures of M.
tuberculosisH37Rv transformed with pST-KT or pST-KT-pknK were grown to an OD600 of0.6 and induced with 1 g/ml ATc for 24, 48, and 72 h (lanes 4, 5,
and 6, respectively). All of the control cultures grown to an OD600 of0.6 were allowed to grow for 72 h with or without inducer. Cell lysates were processed as
described above.
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integrase, various integrating systems have been adopted from
Ms6, Tweety, and Streptomyces C31. Vectors derived from
Ms6 and Tweety integrate at the tRNAAla and tRNALys loci in
the genome, respectively, different from the L5-based vectors
that integrate at tRNAGly (47–49). The integrating pST-KiT vector
for inducible expression is a useful addition to the existing range
of integrating vectors and may prove to be an excellent means for
investigating the functional role of essential genes and for the cre-
ation of conditional gene replacement mutants. The creation of
additional vectors using integration systems derived from other
phages would enable the insertion of multiple genes at different
loci, and expression of proteins in fusion with specific epitopes
would allow analyses of protein-protein interactions without rais-
ing antibodies to the proteins.
The delivery vector pST-KO can be used for gene knockout
studies. Understanding of the complexities of infection and dis-
ease progression relies largely on the identification of important
pathogenic determinants. The creation of gene knockoutmutants
and the characterization of these mutants play an important role
in these studies. Gene knockout/replacement can be performed by
multistep recombination (30), by employing nonreplicating (sui-
cide) vectors (50), by using incompatible plasmids (51), by using
long linear DNA fragments (52), or by mycobacteriophage-medi-
ated single-step delivery (38). The approach of using homologous
recombination for replacement of a gene(s) has always been asso-
ciated with substantial in vitro engineering of suicide delivery vec-
tors. This ismostly due to the availability of only a limited number
of restriction sites, coupled to the large size of the vehicle vector,
which results in cumbersome cloning options and lower transfor-
mation efficiencies, respectively. To circumvent these shortcom-
ings, a suicide delivery vector, pST-KO (4.2 kb), which can be used
with minimal cloning steps, was designed (Fig. 4A). While this
vector is autonomously replicated in E. coli, it cannot replicate in
mycobacteria. It carries an extended MCS along with functional
Hygr and sacB genes.
To establish the successful use of this vector, we took the ap-
FIG 3 Stable expression of PknK in mycobacteria using integrative plasmids. (A) Schematic outline of the creation of constitutive and inducible integrative
shuttle vectors and sequence of the multiple cloning site (MCS) showing the peptide tags and restriction enzyme sites. Tt, transcription terminator. (B)Western
blots showing constitutive expression of PknK from pST-Ki-pknK in M. smegmatis. Extracts (10- and 20-g quantities) were resolved on 8% SDS-PAGE gels,
transferred to PVDF membranes, and probed for endogenous PknB and PknK expressed using the integrated vector, respectively. (C) Western blots showing
inducible expression of PknK from integrative pST-KiT-pknK vector. Cultures ofM. smegmatiswere grown to an OD600 of0.6 and induced with the indicated
ATc concentrations for 14 h. Extracts were resolved and probed as described for panel B.
New Generation of Vectors for Mycobacteria
March 2013 Volume 79 Number 5 aem.asm.org 1723
 o
n
 April 1, 2018 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
proach of utilizing auxotrophic complementation of branched-
chain amino acids (BCAA) as a selectablemarker inM. smegmatis.
Acetohydroxyacid synthase (AHAS; also known as acetolactate
synthase) catalyzes the first universal step of BCAA biosynthesis.
The reaction involves the irreversible decarboxylation of pyruvate
and condensation of the acetaldehydemoiety with either a second
pyruvate molecule or a 2-ketobutyrate molecule to form 2-aceto-
lactate or 2-aceto-2-hydroxybutyrate, respectively (53). Eventu-
ally, isoleucine (Ile), valine (Val), and leucine (Leu) are formed in
parallel reactions (Fig. 4B). AHAS is composed of the IlvB (large)
and IlvH (small) subunits encoded by the ilvB and ilvH genes,
respectively (54, 55). The genomic organization of ilvH and its
flanking regions is illustrated in Fig. 4C. As the ilvH gene codes for
the regulatory subunit of acetohydroxyacid synthase, ilvH dele-
tion is expected to completely stall BCAA synthesis (Fig. 4B). The
delivery construct pST-KO-ilvH, which contains the 5= and 3=
flanks of the ilvH gene (along with the first and last 100 bp of the
gene, respectively) with the apramycin selection marker between
the flanks, was made. Figure 4C depicts how the recombination-
mediated targeted gene replacement was expected to occur. The
hygromycin-resistant colonies obtained after transformation of
M. smegmatis with the linearized pST-KO-ilvH construct were
further screened for sucrose resistance. Among the 60 sucrose-
resistant colonies that were selected for analysis, only 20 were
probable double crossovers (DCOs), as only these colonies were
hygromycin sensitive (Fig. 4D; indicated by white arrowheads).
The 20 probable DCOs were spotted in replicates on 7H10 agar
plates containing (i) only apramycin, (ii) apramycin with BCAA,
and (iii) apramycin with BCAA and hygromycin. None of the
probable M. smegmatis ilvH mutants (DCOs) grew in the ab-
sence of BCAA or in the presence of hygromycin (see Fig. S1 in the
supplemental material). The authenticity of two of the probable
mutants was verified by PCR using ilvH gene-specific primers.
While we could not detect the ilvH amplicon (500 bp) when we
FIG 4 Gene replacement studies in mycobacteria. (A) Pictorial representation of pST-KO vector and its MCS. (B) Illustration of the biosynthetic pathways of
branched-chain amino acids (BCAAs). The white crosses show the impact of ilvH deletion on the BCAA pathway. (C) An overview of the genomic organization
of the ilvBHC locus inM. smegmatis before (upper panel) and after (lower panel) ilvH deletion. Homologous recombination of pST-KO-5=-apr-3=-ilvHwith the
corresponding chromosomal region is depicted. (D) Replica plating for the selection of DCOs. Sixty sucrose-resistant colonies were inoculated in LBCT broth
containing apramycin (Apra) and incubated at 37°C for 24 h. Fourmicroliters of cultures was replica spotted onto LBC agar plates containing only apramycin
or apramycin with hygromycin (Apra  Hygro). Colonies that grew only on apramycin (left panel) but failed to do so in plates containing apramycin plus
hygromycin (right panel) are indicated by white arrowheads. (E) Confirmation of mc2ilvH knockout strains using PCR. Deletion of the targeted region was
confirmed by PCR across the deletion junctions using ilvH gene-specific primers. The templates used for the PCRwere as follows: lane 1, E. coliDH10B genomic
DNA; lane 2,M. smegmatismc2155 genomic DNA; and lanes 4 and 5, genomic DNA from probableM. smegmatismc2ilvHmutants 2 and 8, respectively.
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used E. coli DH10B genomic DNA as the template, the amplicon
was observed whenM. smegmatismc2155 genomic DNAwas used
as the template (Fig. 4E, lanes 1 and 2).When genomic DNA from
probable mutants was used as the template, an amplicon of size
1.3 kb was detected, in keeping with the increase in size due to
the insertion of the apramycin gene marker (Fig. 4E, lanes 4 and
5). This confirmed that the selected clones were mc2ilvH mu-
tants. The inactivation of the large subunit of acetohydroxyacid
synthase, ilvB1has been shown to be auxotrophic (54).Our results
suggest that the small subunit of acetohydroxyacid synthase ilvH is
also essential in the absence of BCAAcomplementation. Thus, our
data clearly demonstrate the successful use of pST-KO as a one-
step tool for the creation of gene replacement mutants.
Protein expression canbe inducedunderhypoxic conditions
using vector pST-KnarK2. Mycobacteria reside in phagosomes of
host macrophages, wherein they face hypoxic conditions along
with other stresses (56). Numerous virulence-associated genes,
which are essential for the survival of mycobacteria in this hostile
environment, are activated under these conditions. Due to the
complications involved in analyses under in vivo infection condi-
tions, in vitro conditions mimicking the in vivo environment are
often used to demarcate specific roles of genes in bacterial patho-
genesis. Studies involving the expression of genes inmycobacteria
under hypoxic conditions so as to simulate the in vivo infection
environment involve the use of vectors carrying promoters that
are active under hypoxic conditions. We modified the pST-K
shuttle vector by replacing the Pmyc1tetO promoter with the hy-
poxia-inducible PnarK2 promoter (31, 57), thus creating the plas-
mid pST-KnarK2 (Fig. 5A). To ensure that expression from the
PnarK2 promoter in the vector is indeed hypoxia inducible, we
cloned gfpaav (coding for a GFP variant having a shorter half-life
[32], which would allow us to monitor gene expression changes)
FIG 5 Generation of hypoxia-inducible shuttle vector. (A) Map of hypoxia-inducible pST-Knark2 shuttle vector. (B) Flow cytometry analysis to check the
expression of GFPaav. The samples were analyzed using the BD FACSCalibur flow cytometer (BD Biosciences) using the excitation wavelength (488 nm), and the
FL1 readout corresponding to GFP fluorescence intensity was plotted on a log scale usingWinMDI (version 2.9) software. (C) Fixed bacterial cells were observed
microscopically using a Carl Zeiss image analyzer system equipped with the Axioplan MPM-400 microscope (Carl Zeiss, Inc., Germany) and KS 300 software,
under a magnification of1,282. Fluorescence was observed with Wayne’s model of hypoxia induction as well as upon providing vitamin C as an inducer of
hypoxia.
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into the EcoRI-HindIII sites of the vector. M. smegmatis trans-
formed with pST-KnarK2-gfpaav plasmid was cultured aerobically
without ascorbic acid (vitamin C), subjected to hypoxic growth
(56), or grown in the presence of vitamin C (58). Expression of
GFP was analyzed by flow cytometry and immunofluorescence
microscopy using Wayne’s model of hypoxia (59) or in the pres-
ence of vitamin C (an inducer of hypoxia) (Fig. 5B and C). The
results of flow cytometry analysis and microscopy indicate that
GFP expression could not be detected under aerobic conditions of
growth (Fig. 5B and C). However, when we mimicked Wayne’s
model of hypoxic growth or used vitaminC to induce hypoxia, the
expression of GFPaav could be detected (Fig. 5B and C). These
results confirm that protein expression using this vector is indeed
hypoxia inducible.
The dual-expression vector pST-2K allows robust coexpres-
sion of two proteins. Various methods such as yeast two-hybrid
assays, bacterial two-hybrid assays, coimmunoprecipitation, and
pulldown studies, are routinely used to investigate protein-pro-
tein interactions. Dual-expression vectors, such as pET-Duet1
(Novagen), are available for tandem expression of proteins with
different epitope tags inE. coli.We have previously used the pDuet
expression system to determine the phosphorylation of enoyl-acyl
carrier protein reductase (InhA) by multiple kinases (60). How-
ever, options for investigating interactions betweenmycobacterial
proteins in their native environment are limited. A shuttle vector
for the constitutive expression of two proteins controlled by inde-
pendent promoters has been made as part of the present study.
This was achieved by the successive cloning of various compo-
nents of the vector, as described in Materials and Methods, creat-
ing a vector, pST-2K, that expresses proteins using the Pmyc1tetO
and Psmyc promoters, in which each MCS carries five unique re-
striction sites (Fig. 6A). Ribosome binding sites and transcription
terminator sequences have been coupled to both promoters or
MCSs. Proteins expressed fromPmyc1tetO carry anN-terminalHis
tag, and those expressed from Psmyc carry a C-terminal FLAG tag
(Fig. 6A).
The essential pknA and pknB genes, encoding protein kinases A
andB, respectively, are part of the same operon (36, 61). PknA and
PknB have been shown to be involved in modulating cell shape,
and possibly cell division, of M. tuberculosis (61). GarA has been
identified as a substrate of PknA and PknB by resolving in vitro
kinase reactions performed with mycobacterial lysates and puri-
fied kinase on two-dimensional (2D) gel electrophoresis followed
bymass spectrometry (62). In an effort to analyze the usefulness of
pST-2K,we cloned the pknB gene to express it under the control of
the Pmyc1tetOpromoter and cloned its cognate substrate garA gene
to express it using the Psmyc promoter. Plasmids carrying one or
both genes were electroporated into M. smegmatis, and Ni-nitri-
lotriacetic acid (NTA) affinity pulldowns and FLAG immunopre-
cipitation were performed on whole-cell lysates. Western blot
FIG 6 Coexpression of proteins in mycobacteria. (A) Map of the shuttle vector pST-2K. Sequences of multiple cloning sites 1 and 2 (MCS1 and -2) of pST-2K
vector are also shown. Peptide tags and restriction enzyme sites are as indicated. (B)Western blot showing the coexpression of PknB-KD (330 amino acids) and
GarA. Cultures ofM. smegmatis transformed with various constructs grown for 24 h were used for preparation of whole-cell extracts. Extracts were mixed with
equilibrated anti-FLAG (Sigma) andNi Sepharose (GEHealthcare) affinity beads for 2 and 4 h at 4°C, respectively, using aNutatormixer. The beadswerewashed
with lysis buffer (composition) and resuspended in SDS sample buffer, resolved, transferred to PVDF membrane, and probed with rabbit anti-PknB (-PknB)
and anti-GarA (-GarA) antibodies. (C) Western blots showing coexpression of PknK or PknK-K55M with VirS. Whole-cell extracts prepared from cultures of
M. smegmatis transformed with various constructs were processed as described above. IP, immunoprecipitate.
Parikh et al.
1726 aem.asm.org Applied and Environmental Microbiology
 o
n
 April 1, 2018 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
analysis of these pulldowns and immunoprecipitates revealed that
PknB and GarA are expressed independently as well as concur-
rently from pST-2K, indicating that both promoters are active
(Fig. 6B). We also coexpressed protein kinase K (PknK) and its
substrate, VirS, using pST-2K. VirS was coexpressed with both
wild-type and kinase-dead (inactive) PknK. Robust coexpression
of PknK and VirS was observed in cells transformed with a plas-
mid carrying both genes (Fig. 6C). It was also apparent fromWest-
ern blot analysis using antiphosphothreonine antibodies that
while we could not detect autophosphorylation of PknK-K55M
(inactive kinase) (29), the wild-type PknK was autophosphory-
lated efficiently (Fig. 6C, upper panel). Our results thus conclu-
sively demonstrate the constitutive and concomitant expression
of two proteins from pST-2K. As the first MCS is under the
Pmyc1tetO promoter, the cloning of tetRmod into the unique SnaBI
site in pST-2K will generate a vector where one protein may be
expressed constitutively and the other only upon induction with
anhydrotetracycline inducer.
This study was undertaken with the aim of expanding the col-
lection of E. coli-mycobacterium shuttle vector systems presently
available. Vectors with expanded multiple cloning sites have been
constructed. These vectors allow proteins to be expressed in fu-
sionwith short epitopes. The shuttle vectors reported in this study
use kanamycin as the antibiotic selection marker. However, vec-
tors with Hygr as the antibiotic selection marker have also been
made in the laboratory, so that one can use either plasmid based
on the need of the experiment. As plasmid size largely influences
transformation efficiency, we have attempted to keep the size of
the vectors to a minimum by using only the essential features of
shuttle vectors.
To generate gene replacement mutants of essential genes or to
overexpress a genewhose product is toxic, it is necessary to express
the target gene under the regulation of inducible promoters.
Though the ectopic and inducible vectors created in the study are
inducible by ATc, they can easily be converted from a tet-on to
tet-off system using the recently engineered reverse tetR repressor
(tetRrev) (25). A simple replacement of tetRmod with reverse tetR
(tetRrev) will convert Tet-responsive inducible pST-KT and pST-
KiT plasmids into Tet-responsive silencing plasmids. In addition
to ATc-regulated expression systems, four other systems (acet-
amide inducible, IPTG inducible, nitrile inducible, and pristina-
mycin inducible) have been reported for the controlled expression
of proteins in mycobacteria (16, 18, 19, 63). The pST series of
vectors reported here have been constructed by stitching together
essential features. Features of other such inducible systems can be
integrated into pST-KT and/or pST-HT using molecular manip-
ulations to generate a gamut of vectors with expanded MCS and
flexible epitope tags. The range of the vectors generated in the
present study can be extended by replacing the N-terminal 6His
tag with other epitope tags, such as glutathione S-transferase
(GST), maltose binding protein (MBP), or GFP. The plasmids
made as part of this study have thus appreciably increased the
options to investigators and are an important addition to the ex-
pression vectors presently available.
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